Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G T Wurz

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
The Journal of Steroid Biochemistry and Molecular Biology|July 18, 2001
In vitro and in vivo biologic effects of Ospemifene (FC-1271a) in breast cancerT L Taras, G T Wurz, M W DeGregorio
Journal of Chromatography. B, Biomedical Sciences and Applications|April 15, 1999
Quantitative analysis of Z-2-[4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy]ethanol in human plasma using high-performance liquid chromatographyT L Taras, G T Wurz, U Hellmann-Blumberg, et al.
Breast Cancer Research and Treatment|November 20, 1998
Intrinsic reactivity of tamoxifen and toremifene metabolites with DNAU Hellmann-Blumberg, M G Cartner, G T Wurz, et al.
Breast Cancer Research and Treatment|June 14, 2000
Genotoxic effects of the novel mixed antiestrogen FC-1271a in comparison to tamoxifen and toremifeneU Hellmann-Blumberg, T L Taras, G T Wurz, et al.
Clinical Pharmacokinetics|December 7, 2000
Clinical pharmacokinetics of toremifeneT L Taras, G T Wurz, G R Linares, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Targeting chemosensitizing doses of toremifene based on protein bindingG T Wurz, V D Emshoff, M W DeGregorio, et al.
Cancer Chemotherapy and Pharmacology|July 28, 2005
Accelerator mass spectrometry allows for cellular quantification of doxorubicin at femtomolar concentrationsM W DeGregorio, K H Dingley, G T Wurz, et al.
Cancer Chemotherapy and Pharmacology|October 15, 1998
Pharmacokinetic analysis of high-dose toremifene in combination with doxorubicinG T Wurz, L Soc, V D Emshoff, et al.
Biochemical and Biophysical Research Communications|February 12, 1998
Haloenol lactone: a new synergist of chemotherapy in vitroJ Zheng, G T Wurz, T B Cadman, et al.
European Journal of Clinical Pharmacology|October 26, 2000
Pharmacokinetics of (deaminohydroxy)toremifene in humans: a new, selective estrogen-receptor modulatorM W DeGregorio, G T Wurz, T L Taras, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
The Journal of Steroid Biochemistry and Molecular Biology|July 18, 2001
In vitro and in vivo biologic effects of Ospemifene (FC-1271a) in breast cancerT L Taras, G T Wurz, M W DeGregorio
Journal of Chromatography. B, Biomedical Sciences and Applications|April 15, 1999
Quantitative analysis of Z-2-[4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy]ethanol in human plasma using high-performance liquid chromatographyT L Taras, G T Wurz, U Hellmann-Blumberg, et al.
Breast Cancer Research and Treatment|November 20, 1998
Intrinsic reactivity of tamoxifen and toremifene metabolites with DNAU Hellmann-Blumberg, M G Cartner, G T Wurz, et al.
Breast Cancer Research and Treatment|June 14, 2000
Genotoxic effects of the novel mixed antiestrogen FC-1271a in comparison to tamoxifen and toremifeneU Hellmann-Blumberg, T L Taras, G T Wurz, et al.
Clinical Pharmacokinetics|December 7, 2000
Clinical pharmacokinetics of toremifeneT L Taras, G T Wurz, G R Linares, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Targeting chemosensitizing doses of toremifene based on protein bindingG T Wurz, V D Emshoff, M W DeGregorio, et al.
Cancer Chemotherapy and Pharmacology|July 28, 2005
Accelerator mass spectrometry allows for cellular quantification of doxorubicin at femtomolar concentrationsM W DeGregorio, K H Dingley, G T Wurz, et al.
Cancer Chemotherapy and Pharmacology|October 15, 1998
Pharmacokinetic analysis of high-dose toremifene in combination with doxorubicinG T Wurz, L Soc, V D Emshoff, et al.
Biochemical and Biophysical Research Communications|February 12, 1998
Haloenol lactone: a new synergist of chemotherapy in vitroJ Zheng, G T Wurz, T B Cadman, et al.
European Journal of Clinical Pharmacology|October 26, 2000
Pharmacokinetics of (deaminohydroxy)toremifene in humans: a new, selective estrogen-receptor modulatorM W DeGregorio, G T Wurz, T L Taras, et al.
Pageof 2